FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Approves Medtronics Pulsed Ablation

FDA approves a Medtronic PMA for the PulseSelect Pulsed Field Ablation System for treating both paroxysmal and persistent atrial fibrillation.

latest-news-card-1
Federal Register

Nagy Debarred for 15 Years

Federal Register notice: FDA issues an order debarring Adam Michael Nagy for a period of 15 years from importing any drug into the U.S.

latest-news-card-1
Marketing

FDA Doing Little on Social Media Drug Claims: Report

A Bloomberg Law article says FDA is doing little to address potentially violative social media drug ads.

latest-news-card-1
Human Drugs

Pharmasol Permanent Injunction Approved

The Massachusetts federal court approves a consent decree of permanent injunction against Pharmasol and its president for continuing to distribute adu...

latest-news-card-1
Human Drugs

Clinical Hold on 3 CARsgen CAR T-cell Therapies

FDA places a clinical hold on three CARsgen Therapeutics clinical trials due to chemistry, manufacturing and controls questions raised in a recent ins...

latest-news-card-1
Human Drugs

Stakeholder Technical Issues with Ophthalmic Guide

Four stakeholders submit specific technical concerns about an FDA draft guidance on topical ophthalmic drug quality considerations.

latest-news-card-1
Human Drugs

FDA Approves Neuroblastoma Drug

FDA approves a U.S. WorldMeds NDA for eflornithine for reducing the risk of relapse in certain adult and pediatric patients with high-risk neuroblasto...

latest-news-card-1
Medical Devices

Update GAO Device Recall Oversight Report: Senators

Sens. Durbin and Blumenthal ask the Government Accountability Office to update its 2011 report on FDA oversight of medical device recalls, given a sex...

latest-news-card-1
Human Drugs

Novid Distributing Unapproved, Misbranded Drug: FDA

FDA warns Northridge, CA-based Novid Group that it is illegally distributing an unapproved and misbranded over-the-counter antihistamine/nasal deconge...

latest-news-card-1
Human Drugs

Vertex Moving Neuropathy Pain Drug to Phase 3

Vertex Pharmaceuticals says it will advance selective NaV1.8 inhibitor VX-548 into pivotal Phase 3 studies based on positive results from its Phase 2 ...